The upcoming Apple Watch Series 10 could sport a thinner design with a bigger display, but it sounds like new health sensors won’t arrive this year. Apple also plans to use a faster processor on its next-gen wearable, possibly laying the groundwork for new AI features.
Bigger and thinner Apple Watch Series 10 incoming
Apple has not given its smartwatch lineup a big redesign in a few years. Since Apple unveiled the Apple Watch in 2014, the Cupertino company could celebrate its 10th anniversary this year.
To commemorate the occasion, Apple plans to introduce significant changes to the watch. Whether the 2024 Apple Watch will carry the anniversary branding remains unclear, though. That’s because the Apple Watch went on sale in 2015, a year after Apple showcased the smartwatch.
Still, in the Sunday edition of his Power On newsletter, Bloomberg reporter Mark Gurman says the 2024 Apple Watch will sport a bigger screen. As usual, the watch will be available in two sizes, with the bigger version’s screen almost as big as the one on the Apple Watch Ultra. Code-named N217 and N218, the two regular Apple Watch models will also be thinner than current versions.
Recently leaked Apple Watch Series 10 CAD renders seem to confirm this, showcasing its notably bigger screen in all its glory.
Apple Watch Series 10 might not launch with new health features
Besides a bigger display and thinner chassis, the Apple Watch Series 10 might not pack any groundbreaking health features. Apple reportedly ran into problems with several health features it was working on for its smartwatch.
This year, the company planned to add high blood pressure monitoring and sleep apnea detection to the Apple Watch. But “serious snags” could delay release of the features, according to Gurman.
Blood pressure monitoring has not worked as reliably as the company would have liked in its testing. Sleep apnea detection might not debut because it relies on blood oxygen monitoring — a feature Apple was forced to remove from the Apple Watch Series 9 and Apple Watch Ultra due to an ongoing patent battle.
